In today’s cosmetic industry, scientific validation has become the foundation of product credibility. Consumers no longer ...

Amperia allows for the accurate quantification of various His-tagged proteins, with consistent performance across a wide ...

The ELISA Test Market's growth is driven by rising infectious and chronic diseases, enhancing demand for accurate diagnostics. Opportunities lie in technological advancements, like point-of-care ...

In addition to PRRSV, the key reagents are available for African swine fever virus and porcine epidemic diarrhea virus.

We are strategically building the team to bolster our capabilities as we scale up our laboratory operations to address the largely untapped $6billion+ U.S. addressable market for CNSide cerebrospinal ...

HIGHLIGHTS Assays confirm the Company’s maiden drillhole, RIBN-DD-001, at the RIB North Discovery as the best exploration hole drilled to date at the Angilak Uranium Project; RIBN-DD-001 assays ...

Explore how Amperia™ combines speed, accuracy, and ease of use to streamline protein quantification and accelerate biologic development.

NANO maintains a strong net cash position, estimated to last 14.5 years without another capital raise, supporting its ...

Opportunities for the In Vitro Diagnostic Industry arise from the monkeypox health emergency, with rapid diagnostics and genomics driving innovation amid a transformed market landscape post-COVID.

Discover what the next wave of AI-assisted drug discovery looks like and how it can help biotech - the AI and physics combo.

The monkeypox outbreak is pushing demand for innovative In Vitro Diagnostic solutions. Key market opportunities include rapid diagnostics and genomics advancements, driven by global testing ...

Pfizer has unveiled phase 3 results that could help the company’s hemophilia drug Hympavzi level the playing field in its ...